ABSTRACT Background: Despite its importance in the central nervous system as a precursor for acetylcholine and membrane phosphatidylcholine, the role of choline in mental illness has been little studied. Objective: We examined the cross-sectional association between plasma choline concentrations and scores of anxiety and depression symptoms in a general population sample. Design: We studied a subsample (n = 5918) of the Hordaland Health Study, including both sexes and 2 age groups of 46-49 and 70-74 y who had valid information on plasma choline concentrations and symptoms of anxiety and depression measured by the Hospital Anxiety and Depression Scale-the latter 2 as continuous measures and dichotomized at a score 8 for both subscales. Results: The lowest choline quintile was significantly associated with high anxiety levels (odds ratio: 1.33; 95% CI: 1.06, 1.69) in the fully adjusted (age group, sex, time since last meal, educational level, and smoking habits) logistic regression model. Also, the trend test in the anxiety model was significant (P = 0.007). In the equivalent fully adjusted linear regression model, a significant inverse association was found between choline quintiles and anxiety levels (standardized regression coefficient = 20.027, P = 0.045). We found no significant associations in the corresponding analyses of the relation between plasma choline and depression symptoms.
INTRODUCTION
Choline is an essential nutrient found in animal products such as liver, egg, and meat, but also in some vegetable products, including wheat germ and soy beans (1) . Despite the presence of a pathway for endogenous synthesis of choline, a choline-deficient diet impairs growth, memory, and hepatic, renal, and pancreatic functions in mammals (2) . Choline plays an important role in the central nervous system, both for the synthesis of membrane phosphatidylcholine and for acetylcholine (3) .
Disturbed cholinergic transmission affects cognitive function (4); however, its influence on emotional regulation is less known (5) . On the basis of animal studies and drug effects, Janowsky et al (6) postulated that there is relative or actual cholinergic hyperactivity in depression and the opposite in mania. However, no attempts have been made to test this hypothesis. In a case report of 2 patients with tardive dyskinesia, large doses of choline induced depressive symptoms in both patients (7) . In an openlabel clinical trial, patients (n = 13) with Alzheimer disease showed no significant change in the mean Geriatric Depression Scale score after treatment with tetrahydroaminoacridine (an acetylcholine-esterase inhibitor) and lecithin (phosphatidylcholine) for 10 wk (8) . In a crossover, double-blind, placebo-controlled trial, patients (n = 11) with mania showed a significant improvement after 1 wk of treatment with lecithin, but not with placebo (9) . In an open-label study, treatment-refractory rapid cycling bipolar patients (n = 6) taking mood-stabilizing medication had a reduced level of mania and other mood symptoms after treatment with choline bitartrate for 1 wk (10) . During the past decade, there has been an interest in choline as a marker of neuronal activity in imaging studies with magnetic resonance spectroscopy. However, the number of studies has been few (11) (12) (13) (14) , and it is difficult to draw specific conclusions other than that choline concentrations in the central nervous system may be disturbed in mental illness.
In the present study we investigated the associations between plasma choline concentrations and anxiety and depression in a large sample of middle-aged and elderly men and women from the general population.
SUBJECTS AND METHODS

Subjects
The Hordaland Health Study was conducted from 1997 to 1999 as a collaboration between the National Health Screening Service, the University of Bergen, and local health services. In a subsample of the study, 9187 men and women aged 46-49 and 70-74 y who had participated in the Hordaland Homocysteine Study in 1992-1993 (15) were invited to participate; 7074 (77%) participated in the Hordaland Health Study. The subjects underwent a brief physical examination (height, weight, and blood pressure). Blood samples used for the preparation of plasma were drawn into evacuated tubes containing EDTA, placed in a refrigerator (4-5°C) within 15-30 min, and centrifuged, usually within 1 h (always within 3 h). EDTA plasma was stored at 280°C. The analyses of blood samples were completed in 2006; thus, plasma was stored for 7 to 9 y.
Information on health behaviors, subjective health, current or former diseases, use of medications, and demographic, socioeconomic, and psychosocial variables was obtained with a selfadministered questionnaire. The study population included 5918 subjects with valid data on anxiety and depression symptoms, plasma choline, educational level, and smoking habits. The study protocol was approved by the Regional Committee for Medical Research Ethics and the Norwegian Data Inspectorate. All participants signed a consent form.
Assessment of anxiety and depression
The Hospital Anxiety and Depression Scale (HADS) (16) is a self-administered questionnaire consisting of 14 items, 7 for anxiety (HADS-A subscale) and 7 for depression (HADS-D subscale). So that individuals do not feel as though they are being tested for mental disorders, symptoms of severe psychopathology are not included. HADS-A contains items mainly related to restlessness and worry and one item that reflects panic attacks. HADS-D focuses mainly on the reduced pleasure response aspect (anhedonia) of depression but also on psychomotor retardation and impaired mood. High anxiety levels were defined as a HADS-A 8 and high depression levels as a HADS-D 8 (17).
Biochemical measurements
Plasma free choline, betaine, and dimethylglycine were measured by using a method based on normal-phase chromatography-tandem mass spectrometry (18) .
Statistical analyses
Logistic regression analyses were used to estimate odds ratios (OR) for being a case, comparing each quintile (quintile 1: 4.09-7.96 lmol/L; quintile 2: 7.97-9.08 lmol/L; quintile 3: 9.09-10.10 lmol/L; quintile 4: 10.11-11.58 lmol/L) with the reference quintile (quintile 5: 11.60-24.70 lmol/L) of plasma choline in the total study population. The representation of the choline quintiles as indicator variables was used to allow for assessment of nonlinear dose-response relations, whereas a linear (1 df) representation was used to test for linear trends. Two logistic regression models were used, one with adjustment for age group, sex, and time since last meal (model 1) and one with additional adjustments for smoking status (smokers compared with nonsmokers and ex-smokers) and educational level (,10, 10-12, and .12 y) (model 2). To evaluate the possible effect modification of age, sex, and methylenetetrahydrofolate reductase 677 C/T polymorphism, product terms were added separately to the models. Two linear regression models were used, corresponding to the The precision of the OR estimates was expressed with 95% CIs. Generalized additive logistic regression was used to provide a graphic representation of the dose-response relation between choline and high anxiety and depression levels. This technique is based on the generalized additive model (19) and allowed adjustment for age, sex, time since last meal, smoking status, and educational level. A 2-sided P value ,0.05 was chosen to indicate statistical significance. The statistical analyses were conducted by using the software package SPSS 15.0 and S-Plus 6.1 (SPSS Inc, Chicago, IL).
RESULTS
Characteristics of the study population
The total numbers of subjects with high anxiety (HADS-A 8) or depression (HADS-D 8) levels were 929 (15.7%) and 550 (9.3%), respectively. High anxiety levels were most prevalent among middle-aged women (19.9%) and high depression levels were most prevalent among older men (10.1%). The educational level was higher among the middle-aged subjects, and this difference was most pronounced among women. Current smoking was more common among the middle-aged (29.5%) than among the older (12.2%) subjects, with only minor sex differences. The mean (6SD) plasma choline concentration was 9.87 6 2.30 lmol/L, was lower in women than in men, and was lower in younger than in older subjects (20) . Among subject with the shortest time (,2 h) since the last meal, mean plasma choline was highest (10.15 lmol/L) and gradually decreased in the next groups (2-3 h 59 min: 9.85 mol/L; 4-5 h 59 min: 9.42 lmol/L) to the lowest concentration (9.20 lmol/L) in subjects with the longest time (6 h) since the last meal.
Univariate associations
The proportion of participants with high levels of anxiety or depression symptoms according to sex, age group, time since last meal, educational level, smoking habit, and choline quintiles is shown in Table 1 . There was a negative association between choline concentrations and anxiety symptoms (P , 0.001) but not depression symptoms (P = 0.622). Higher educational levels (negatively) and current smoking (positively) were associated with both anxiety (P = 0.003 and P , 0.001, respectively) and depression (P , 0.001 and P , 0.001, respectively) symptom levels. A higher proportion of women than men reported anxiety symptoms (P , 0.001), whereas no sex differences were seen for depression. A higher proportion in the middle than in the oldest aged group reported anxiety symptoms (P , 0.001), and a higher proportion in the oldest than the middle aged group reported depression symptoms; however, it was of borderline significance (P = 0.053).
Multivariate associations
In the logistic regression analyses ( Table 2 ), significant associations were found only between choline and high anxiety levels. Furthermore, only the lowest choline quintile was The trend tests for these models were significant (P = 0.004 and P = 0.007 for models 1 and 2, respectively). Adjustments for coffee consumption, physical exercise, body mass index, cardiovascular disease, and serum creatinine were performed as well and had essentially no effect on the associations between plasma choline and anxiety. There was no significant effect modification of age (P = 0.525) or of the methylenetetrahydrofolate reductase 677 C/T polymorphism (P = 0.944) on the association. The choline-sex interaction was significant (P = 0.010); however, when stratified on sex, no significant associations between choline and anxiety symptoms were found (data not shown). In the logistic regression models predicting high depression levels, no significant associations were found for either separate choline quintiles or trend through the choline quintiles. A significant inverse association was also found by linear regression analyses, only between choline and anxiety levels ( Table 3) , after adjustment for sex, age group, and time since last meal [standardized regression coefficient (b) = 20.030, P = 0.028]. Further adjustment for smoking and educational level somewhat weakened the association (b = 20.027, P = 0.045). In the linear regression models predicting depression symptoms, no significant associations were found.
An inverse dose-response association between plasma choline concentrations and high anxiety symptom levels and a possible inverse dose-response association between plasma choline concentrations and high depression symptom levels were indicated by the generalized additive model analyses (Figure 1) . Because of the increasing widening of the 95% pointwise CI toward the tails of the distribution [plasma choline ,7.0 lmol/L (8th percentile) and .12.0 lmol/L (84th percentile)], these values are not shown.
Having access to the concentration of plasma betaine and dimethylglycine from the assessment process of plasma choline (chromatography-tandem mass spectrometry), the associations between these metabolites and symptoms of anxiety and depression were analyzed as well, however, without any significant findings (data not shown).
DISCUSSION
We investigated the association between plasma choline concentrations and anxiety and depression symptoms in a cohort of 5918 community-dwelling subjects and found that choline was inversely related to anxiety, but not to depression symptoms.
The present study has a cross-sectional design. Although this design allows the assessment of associations between variables, causality could not be determined. Because high levels of anxiety and depression may influence dietary habits, it is conceivable that these mental conditions may alter choline status through dietary changes. Unfortunately, we did not have information on dietary choline intake.
Although the primary participation rate of the present study was relatively high (77%), the recruitment might have been affected by mental disorders themselves, because persons with high levels of anxiety and depression symptoms may have been less likely to participate. Hence, selection bias cannot be ruled out. However, in this study, such possible bias would probably attenuate the true associations because of reduced variance in the outcome measure. There has probably been no or only minor change in free choline during storage of the EDTA samples before analysis. Stability of free choline in the presence of EDTA and at a low temperature was previously documented (18) and is corroborated by the mean choline concentration (9.87 lmol/L) of the study population not exceeding the concentration previously measured in fresh EDTA samples from nonfasting healthy subjects (18) . Furthermore, instability of plasma choline would have attenuated rather than strengthened the observed associations.
We studied free circulating choline, which is a precursor of brain acetylcholine. Acetylcholine is of great importance in cognitive function and diseases, including Alzheimer disease (21) . Impaired cognitive function might cause problems with the management of daily life tasks, which in turn might increase the level of anxiety symptoms. However, in a substudy of the oldest age group (n = 1930) in whom cognitive function was assessed, we found no association between cognitive function and anxiety symptoms (22) .
Data on the role of acetylcholine in other mental disorders and in emotional regulation in humans in particular are sparse (5) . In animal models (rats), dorsal hippocampal cholinergic transmission mediates an anxiolytic effect (23) . Nicotine, an acetylcholine receptor agonist, affects anxiety in both animal and human studies (24) . Stress, an anxiety component, induces an increase in adrenal catecholamines, which increases the demand for methylation reactions required in norepinephrine and adrenaline synthesis (25) . Synthesis of biogenic amines may increase the demand for one-carbon units for methionine synthesis, derived from choline, as well as folate-dependent pathways. However, we found no associations between components of one-carbon metabolism and anxiety symptoms in a previous study of the same population (26) . In summary, results from this large population-based study suggest a role of choline in anxiety disorders. However, our results are preliminary, and prospective studies need to be conducted.
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